Venture • Life Science

Eight Roads Invests In Elucidata

On September 27, 2022, private equity firm Eight Roads invested in life science company Elucidata

Investment Context

This is Eight Roads’ 71st transaction in the Life Science sector.
This is Eight Roads’ 118th transaction in the United States.
This is Eight Roads’ 41st transaction in California.

Explore All 557 Venture Life Science Deals - Search the Database Free

Investment Summary
Date	September 27, 2022
Target	Elucidata
Sector	Life Science
Investor(s)	Eight Roads
Deal Type	Venture

Target Company

Elucidata

San Francisco, California, United States

Elucidata is a life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. Elucidata was founded in 2015 and is based in San Francisco, California.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor

Category	Private Equity Firm
Founded	1969
PE ASSETS	11.0B USD
Size	Mega
Type	Sector Focused

DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

Deal Context for Investor	#
Overall	291 of 293
Sector: Life Science	71 of 73
Type: Venture	264 of 266
State: California	41 of 42
Country: United States	118 of 119
Year: 2022	22 of 23

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2022-09-14	Qixiangyun Beijing, China Qixiangyun is a developer of an enterprise finance and taxation information system. Qixiangyun mainly based on an open platform architecture, with an intelligent financial and tax report accounting engine as the core, it provides APIs and configurable functional modules that can be integrated by any enterprise software system. Qixiangyun is based in Beijing, China.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2022-09-14

Qixiangyun

Beijing, China

Qixiangyun is a developer of an enterprise finance and taxation information system. Qixiangyun mainly based on an open platform architecture, with an intelligent financial and tax report accounting engine as the core, it provides APIs and configurable functional modules that can be integrated by any enterprise software system. Qixiangyun is based in Beijing, China.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2022-10-26	more2 London, United Kingdom more2 is a data analytics and marketing platform that provides strategy, segmentation and modeling, reporting and analysis, technology, and campaign services to grow retail businesses in the United Kingdom and internationally. It serves fashion, fitness, food and drink, health and beauty, lifestyle, outdoor, and technology clients. more2 was founded in 2002 and is based in London, United Kingdom.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2022-10-26

more2

London, United Kingdom

more2 is a data analytics and marketing platform that provides strategy, segmentation and modeling, reporting and analysis, technology, and campaign services to grow retail businesses in the United Kingdom and internationally. It serves fashion, fitness, food and drink, health and beauty, lifestyle, outdoor, and technology clients. more2 was founded in 2002 and is based in London, United Kingdom.

Sell

Explore Related M&A Activity

Life Science M&A - Venture M&A Deals - California M&A - United States M&A - 2022 M&A